In eukaryotic cells, surveillance mechanisms detect and respond to DNA damage by triggering cell-cycle arrest and inducing the expression of DNA-repair genes [ 
Results and discussion

DNA damage triggers disruption of telomeric silencing
To determine whether DNA damage disrupts telomeric silencing in S. cerevisiae, we used strain YP4 (TEL::URA3), which contains the URA3 gene adjacent to the telomere of chromosome VII-L. In this strain, the proportion of cells that are resistant to 5-fluoro-orotic acid (5-FOA), which is toxic to cells expressing URA3, indicates the level of silencing at the telomere. To test the effects of DNA damage on telomeric silencing, we used the radiomimetic drug bleomycin, which generates DNA DSBs and other forms of DNA damage [7] . Serial dilutions of TEL::URA3 and its isogenic wild-type strain, W303, were spotted onto synthetic complete (SC) medium containing or lacking 20 µg/ml bleomycin, in either the presence or the absence of 5-FOA ( Figure 1a ).
As expected, a control strain disrupted in SIR3 (∆sir3) did not grow in the presence of 5-FOA because the telomeric URA3 was completely derepressed (Figure 1a) , and a rad52 mutant strain, defective in homologous recombination (the main DSB repair pathway in yeast), grew well in the absence but not in the presence of bleomycin (data not shown). Growth of none of the strains was impaired markedly by the addition of bleomycin alone, and the presence of 5-FOA alone had no significant effect on the growth of the wild-type strain ( Figure 1a ). The addition of 5-FOA alone reduced the growth rate of the TEL::URA3 strain somewhat (Figure 1a) , although the plating efficiency and viability of TEL::URA3 was not significantly impaired. This suggests that the TEL::URA3 strain expresses URA3 to some extent even under normal growth conditions. Whereas the combination of 5-FOA and bleomycin had only a minor deleterious effect on the growth of the wild-type strain, the presence of these two agents reduced growth of TEL::URA3 dramatically. W303 contains a mutation in RAD5 (rad5-535), which affects the relative use of the homologous recombination and NHEJ pathways [8] . To control for the rad5 mutation in W303, we repeated the experiments in strains that are RAD5 + , with essentially identical results (data not shown). These data demonstrate that telomeric silencing is disrupted when DSBs are induced by bleomycin.
Disruption of telomeric silencing is reversible
To determine whether the derepression of telomeric silencing is reversible, we assayed the expression of an ADE2 reporter gene that was integrated adjacent to the telomeric repeats of chromosome VII-L (TEL::ADE2). When this strain is plated onto medium (YPD) containing minimal adenine, expression of ADE2 results in white colonies, whereas repression of the ADE2 gene produces red/pink colonies. Initially, we picked a single red colony and re-streaked it onto medium lacking or containing 10 µg/ml bleomycin. The colony colour remained red in the absence of bleomycin, whereas predominantly white colonies formed on bleomycin-containing plates (Figure 1b , upper panels). To control for any effects of bleomycin on pigment accumulation, an ade2 mutant strain was included. This strain remained red in the presence or absence of bleomycin (Figure 1b , lower panels). These data confirm our initial finding that bleomycin treatment results in expression of telomeric reporter genes. Next, we picked a white colony from the bleomycin plate and re-streaked it onto YPD (with no bleomycin) and observed that the majority of colonies switched back to the repressed, red state (Figure 1b) . Thus, the disruption of telomeric silencing by bleomycin is reversible.
Sir3p relocates upon induction of DNA damage
One explanation for the above results is that the Sir proteins dissociate from the telomeric DNA upon bleomycin treatment. We tested this possibility using an affinitypurified antibody and indirect immunofluorescence microscopy to visualise Sir3p localisation. As shown previously for diploid yeast strains [9] , Sir3p was localised in a few concentrated foci predominantly at the nuclear periphery (Figure 2a,e) . In a strain disrupted for SIR3, no Sir3p immunofluorescence signal was detected, demonstrating the specificity of the anti-Sir3p antibodies Figure 2l ). In cells damaged with bleomycin, the discrete peripheral foci seen in W303 were lost and, instead, Sir3p was distributed diffusely throughout the nuclei (Figure 2b,f) . Western blotting demonstrated that the increase in immunofluorescence following bleomycin treatment was not due to increased levels of Sir3p (Figure 2l ). Although changes in epitope accessibility cannot be ruled out, these data suggest that Sir3p relocates following bleomycin treatment. Relocation of Sir3p was not restricted to cells that were arrested at G2/M phase following bleomycin treatment. In addition, arrest of W303 cells in G1 phase with α-factor did not trigger relocation of Sir3p (data not shown). These data suggest that relocation of Sir3p is not due to cell-cycle arrest/disruption but is part of a DNA-damage response. Furthermore, treatment with bleomycin does not simply lead to disruption of nuclear architecture, because this agent did not alter the localisation of the 2µ-circle-associated factor Rep1p which, in untreated cells, is in foci that differ from the Sir3p foci (Figure 2g ,h; [10] and data not shown).
Sir3p relocation and disruption of telomeric silencing are induced by a single chromosomal DNA DSB
To investigate further the potential involvement of DNA DSBs in inducing Sir3p relocation and disruption of telomeric silencing, we tested the effects of inducing a single genomic DSB with the HO endonuclease. Thus, W303 cells were transformed with a plasmid that expressed HO endonuclease under the control of the GAL1-10 promoter (pGAL:HO), or with an empty vector (pRS416). When grown in the presence of galactose, the HO endonuclease is continually expressed, resulting in repeated cleavage of a single DNA DSB at the MAT locus. Strikingly, as shown in Figure 3a (right panel), induction of HO endonuclease triggered the relocation of Sir3p, leading to its diffuse staining throughout the nucleus. In contrast, Sir3p remained in discrete peripheral foci in cells carrying the empty vector that were grown in the presence of galactose (Figure 3a ; left panel). Western blotting demonstrated that Sir3p levels were unaffected by expression of HO endonuclease ( Figure 3b ). Next, we determined whether induction of HO endonuclease disrupts telomeric silencing. To do this, the TEL::ADE2 strain was transformed with an empty vector, or with the plasmid expressing HO endonuclease, and a single colony of each strain was streaked onto galactose medium containing minimal adenine to assess colony colour and, thereby, telomeric silencing. As shown in Figure 3c , cells expressing the HO endonuclease were predominantly white, whereas control cells carrying the empty vector were red/pink. Together with the Sir3p immunofluorescence studies, these data reveal that a single genomic DNA DSB is sufficient to induce Sir3p relocation and disruption of telomeric silencing.
Relocation of Sir3p requires DNA damage checkpoint components
The above results suggest the involvement of a DNA damage-signalling pathway. We therefore examined the effects of bleomycin on strains mutated in genes involved in DNA-damage signalling. First, we studied a strain in which MEC1 was disrupted. In contrast to wild-type yeast, treatment of the mec1 strain with bleomycin had no effect on the location of Sir3p in foci at the nuclear periphery ( Figure 4 ). These results indicate that functional Mec1p is essential for the effective relocation of Sir3p following DNA damage. We also examined Sir3p location before and after bleomycin treatment in cells disrupted in TEL1, a gene that has high homology to MEC1, and functions in DNA-damage signalling in a partially redundant manner with MEC1 [11] . Following bleomycin treatment, tel1 mutant cells relocated Sir3p (Figure 4 ), indicating that Tel1p is not essential for Sir3p relocation. Next, we examined a strain disrupted in the RAD53 gene, whose product is a protein kinase that functions downstream of Mec1p [12] . Although analysis is difficult in the rad53 mutant because there is some Sir3p mislocalisation even in the absence of bleomycin, it was apparent that Sir3p became more diffuse in the nucleus of this strain after bleomycin exposure ( Figure 4) . Thus, Rad53p is not essential for Sir3p relocation after bleomycin treatment. We also analysed a strain disrupted for DDC1, a gene that acts Brief Communication 965 Tubulin genetically together with or upstream of MEC1 [13] . The ddc1 mutant strain had the same phenotype as the MEC1-disrupted strain, in that it failed to induce diffuse Sir3p staining following bleomycin treatment (Figure 4 ).
The role of Sir3p in the response to DNA damage
These data suggest that a pathway dependent on Mec1p and Ddc1p triggers the release of Sir3p from the telomere following DNA damage. Consistent with this idea, while this paper was in revision, two other groups reported similar findings that Sir proteins and Ku relocate in yeast after DNA damage, associate with sites of DNA DSBs and appear to play a role in NHEJ independent of mating-type status [14, 15] . It is tempting to speculate that release of Sir3p from telomeres is mediated by modulating the interactions between Sir3p and telomere-targeting factors such as Yku70p/Yku80p and/or Rap1p. Release of Sir proteins and Ku may allow their direct participation in DNA DSB repair. Alternatively, or in addition, Sir protein relocation could induce changes in chromatin structure to bring about coordinated transcriptional responses to DNA damage. Sir protein relocation may also serve to shutdown temporarily and stabilise essential nuclear processes, such as DNA replication and transcription, while the repair of potentially lethal DNA damage takes place. In this way, Sir proteins could contribute to genomic stability by multiple mechanisms.
Supplementary material
Additional data, methodological details and yeast genotypes are available at http://current-biology.com/supmat/supmatin.htm.
Figure 4
DNA-damage checkpoint-signalling components are crucial for Sir3p relocation. Untreated or bleomycin-treated strains were stained with anti-Sir3p antibody or DAPI, as indicated. Strains used were wild-type strain W303; ∆mec1 strain U953-61A; ∆tel1 strain Y654; ∆rad53 strain U960-5C; and ∆ddc1 strain YLL244. 
Supplementary materials and methods
Yeast strains, media and plasmids
Yeast strains used in this study are described in Table S1 . Non-selective medium (YP) and selective media (SC) were prepared as described previously [S1]. Medium containing 5-FOA, with or without bleomycin, was prepared as follows. Bleomycin (Kyowa) was resuspended in sterile water to a concentration of 10 mg/ml. The appropriate amount of bleomycin was added to 7.5 ml aliquots of solution A (10 µg/ml uracil with or without 0.1% 5-FOA; Melford laboratories) and stored at 4°C. Solution B (0.67% yeast nitrogen base -AA/AS, 2% dextrose, 2% agar and 20 mg/ml of each tryptophan, lysine, histidine and leucine) containing 0.8 mg/ml amino-acid drop-out mix was autoclaved and allowed to cool to 55°C. Solution B (7.5 ml) was then added to 7.5 ml solution A at room temperature, mixed gently and poured into Petri dishes. Plates were dried, stored at room temperature and used within 24 h.
Silencing assays
Assays for silencing using the TEL::URA3 reporter were carried out by inoculating a single colony into 10 ml liquid YPD or the appropriate synthetic (SC) selective medium and incubating overnight at 30°C. The next day, the culture was diluted to a density of 1 × 10 7 cells per ml in sterile water, and 7.5 µl aliquots of 10-fold serial dilutions were spotted onto the appropriate selective medium as described above. Plates were incubated at 30°C for 3-4 days before the strength of silencing was assessed. For the TEL::ADE2 reporter, single red colonies were streaked onto YPD containing the appropriate concentration of bleomycin, then incubated for 3 days before placing at 4°C for 1-2 weeks to allow pigment accumulation. Table S1 Yeast strains used in this study. 
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